Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Sold by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP decreased its holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 19.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 785,494 shares of the biotechnology company’s stock after selling 188,989 shares during the quarter. Westfield Capital Management […]

Related Keywords

United States ,N Anthony Coles ,Westfield Capital Management Co ,Cerevel Therapeutics Holdings Inc ,Exchange Commission ,Cerevel Therapeutics Company Profile ,Nasdaq ,Calamos Advisors ,Charles Schwab Investment Management Inc ,Westfield Capital Management ,Cerevel Therapeutics Holdings ,Free Report ,Capital Management ,Cerevel Therapeutics ,Bay Capital Management ,Charles Schwab Investment Management ,Schwab Investment Management ,Therapeutics Holdings ,Directorn Anthony Coles ,Visit Holdingschannel ,Cerevel Therapeutics Daily ,